Science and Law
30th January 2014

Top 25 Adverse Drug Reaction Articles Drug and Device Lawyers Should Have

Every drug or device product liability case involves issues involving adverse event (AE) reporting or adverse drug reaction (ADR) reporting. We have discussed some of the nuanced differences between ADRs and AEs in a previous post.  For purposes of the current post, we will use the general term ADR.

Top 25 Adverse Drug Reaction Articles Drug and Device Lawyers Should Have

Every drug or device product liability case involves issues involving adverse event (AE) reporting or adverse drug reaction (ADR) reporting. We have discussed some of the nuanced differences between ADRs and AEs in a previous post.  For purposes of the current post, we will use the general term ADR.

Of course, ADRs are uncontrolled anecdotal evidence and their existence should never be used as evidence of a causal relationship between a drug and an adverse health event. Nevertheless, their existence cannot be ignored and a good drug and device lawyer must be comfortable addressing what they can and what they cannot be used to demonstrate.

Common pro-defense arguments related to ADRs include the following:

  • Unreliability of ADR reporting in ultimately determining causation

  • The plaintiff’s condition differed from the ADRs in the FDA’s adverse event database (FAERS)

  • Small number of ADRs fail to support general causation

  • Good corporate responsibility by diligent ADR reporting

Common pro-plaintiff arguments that must be responded to include the following:

  • Alleged failure of Defendant to capture ADRs in a timely fashion

  • Alleged failure of defendant to respond to a safety signal based on ADRs

Whatever issues you confront as a drug and device lawyer, it is critical that you have a good handle on the scientific literature related to ADRs. We have put together a listing of what we consider to be the 25 most important articles published in the peer-reviewed scientific literature on this topic.

To download this literature list, simply fill out the form below.

  • This field is for validation purposes and should be left unchanged.

Recent Related Articles

Dr. David Schwartz’s IADC Presentation: The Use of Genetic Testing in the Courtroom [Download Slides]
15 July 2020
Dr. David Schwartz’s IADC Presentation: The Use of Genetic Testing in the Courtroom [Download Slides]

On Wednesday July 8, 2020, Dr. David Schwartz of Innovative Science Solutions presented at the IADC 2020 Virtual Annual Meeting on a panel titled The Use of Genetic Testing in the Courtroom. A complimentary copy of the panel presentation is now available for download. Read more

The Use of Genetic Testing in the Courtroom: Dr. David Schwartz will be Presenting at the IADC 2020 Virtual Annual Meeting
02 July 2020
The Use of Genetic Testing in the Courtroom: Dr. David Schwartz will be Presenting at the IADC 2020 Virtual Annual Meeting

Dr. David Schwartz of Innovative Science Solutions will be presenting at the IADC 2020 Virtual Annual Meeting on a panel titled The Use of Genetic Testing in the Courtroom. Read more

WEBINAR ANNOUNCEMENT: What’s in Those Genes?
12 June 2020
WEBINAR ANNOUNCEMENT: What’s in Those Genes?

Genetic Evidence Concerning Causation for Mesothelioma 16 June 2020 at 2pm Eastern Daylight Time. Read more

Talc and Asbestos Defendants Should Monitor and Utilize Published Studies Linking Mesothelioma to Genomic Causes
28 April 2020
Talc and Asbestos Defendants Should Monitor and Utilize Published Studies Linking Mesothelioma to Genomic Causes

Plaintiff experts having been asserting for decades that all mesotheliomas must be linked to some asbestos exposure. Indeed, this has led to the erroneous (but widespread) view that mesothelioma is a signature disease, only caused by asbestos exposure. Read more

Let’s work together

The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us today

Contact us